Vimentin network dysregulation mediates neurite deficits in SNCA duplication Parkinson’s patient–derived midbrain neurons
Science Advances · 2025
DOI: 10.1126/sciadv.adq2742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Yanni Schneider und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Vimentin, Mesencephalon. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Duplication of the SNCA gene ( SNCA Dupl ), linked to elevated levels of α-synuclein (aSyn), is a genetic cause of Parkinson’s disease (PD). Our prior work with human-induced pluripotent stem cell (hiPSC)–derived midbrain neurons generated from patients with PD SNCA Dupl identified neuritic deficits, accompanied by decreased levels of cytoskeletal element β-tubulin-III (bTubIII). To explore mechanisms underlying these effects in SNCA Dupl neurons, we used CRISPR-Cas9 to generate isogenic control hiPSCs. Isogenic correction of SNCA dosage restored SNCA Dupl -induced neurite defects and bTubIII levels. Multi-omics analyses revealed SNCA Dupl -induced alterations in neuronal differentiation, with a notable down-regulation of PAX6. Moreover, SNCA Dupl induced an up-regulation of vimentin. Further characterization revealed heightened vimentin truncation associated with altered distribution and organization. Similar changes in vimentin levels and truncation were observed in postmortem putamen tissue from patients with sporadic PD. Notably, targeting vimentin with okadaic acid and withaferin A restored bTubIII- and neurite-associated defects, suggesting its potential to prevent aSyn-mediated neuritic degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
- Department of Chemistry, Ludwig Maximilian University München, Würmtalstrasse 201, 81375 Munich, Germany.
- Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
- Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.
ORCID-Profile: Yanni Schneider, Aron Koller, Marie Andert, Laura Hoffmann, Sydney O'Brien, Pavel Kielkowski, Johannes C M Schlachetzki, Wei Xiang
Zitieren
APA
Schneider, Y., Koller, A., Schweigert, A., Andert, M., Hoffmann, L., O'Brien, S., Seebauer, L., Plötz, S., Kielkowski, P., Winkler, J., Schlachetzki, J. C. M., & Xiang, W. (2025). Vimentin network dysregulation mediates neurite deficits in SNCA duplication Parkinson’s patient–derived midbrain neurons. Science Advances. https://doi.org/10.1126/sciadv.adq2742
Vancouver
Schneider Y, Koller A, Schweigert A, Andert M, Hoffmann L, O'Brien S, et al. Vimentin network dysregulation mediates neurite deficits in SNCA duplication Parkinson’s patient–derived midbrain neurons. Science Advances. 2025. doi:10.1126/sciadv.adq2742
BibTeX
@article{Schneider2025,
author = {Schneider, Yanni and Koller, Aron and Schweigert, Alina and Andert, Marie and Hoffmann, Laura and O'Brien, Sydney and Seebauer, Lukas and Plötz, Sonja and Kielkowski, Pavel and Winkler, Jürgen and Schlachetzki, Johannes C M and Xiang, Wei},
title = {Vimentin network dysregulation mediates neurite deficits in SNCA duplication Parkinson’s patient–derived midbrain neurons},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adq2742}
}
EUVIMED